These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 3805529

  • 61.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 62. Amiodarone therapy: role of early and late electrophysiologic studies.
    Greenspon AJ, Volosin KJ, Greenberg RM, Jefferies L, Rotmensch HH.
    J Am Coll Cardiol; 1988 Jan; 11(1):117-23. PubMed ID: 3335688
    [Abstract] [Full Text] [Related]

  • 63. Nonsustained ventricular tachycardia during programmed ventricular stimulation: criteria for a positive test.
    Platia EV, Reid PR.
    Am J Cardiol; 1985 Jul 01; 56(1):79-83. PubMed ID: 4014044
    [Abstract] [Full Text] [Related]

  • 64.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 65.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 66.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 67. Benefit and risks of long-term amiodarone therapy for sustained ventricular tachycardia/fibrillation: minimum of three-year follow-up in 145 patients.
    Myers M, Peter T, Weiss D, Nalos PC, Gang ES, Oseran DS, Mandel WJ.
    Am Heart J; 1990 Jan 01; 119(1):8-14. PubMed ID: 2296879
    [Abstract] [Full Text] [Related]

  • 68. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
    McKenna WJ, Oakley CM, Krikler DM, Goodwin JF.
    Br Heart J; 1985 Apr 01; 53(4):412-6. PubMed ID: 4039188
    [Abstract] [Full Text] [Related]

  • 69.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 70.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 71.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 72.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 73.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 74. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
    Rae AP, Kay HR, Horowitz LN, Spielman SR, Greenspan AM.
    J Am Coll Cardiol; 1988 Jul 01; 12(1):131-9. PubMed ID: 3379198
    [Abstract] [Full Text] [Related]

  • 75.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 76. Efficacy and safety of combination therapy with amiodarone and type I agents for treatment of inducible ventricular tachycardia.
    Jung W, Mletzko R, Manz M, Nitsch J, Lüderitz B.
    Pacing Clin Electrophysiol; 1993 Apr 01; 16(4 Pt 1):778-88. PubMed ID: 7683805
    [Abstract] [Full Text] [Related]

  • 77. Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia.
    Wichter T, Borggrefe M, Haverkamp W, Chen X, Breithardt G.
    Circulation; 1992 Jul 01; 86(1):29-37. PubMed ID: 1617780
    [Abstract] [Full Text] [Related]

  • 78.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 79. Predictive value of early electrophysiologic testing in determining long-term outcome with amiodarone treatment in patients with sustained ventricular tachycardia.
    Shannon JA, Hammill SC, Gersh BJ.
    Mayo Clin Proc; 1991 Nov 01; 66(11):1114-9. PubMed ID: 1943242
    [Abstract] [Full Text] [Related]

  • 80. Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity.
    Kerin NZ, Blevins RD, Benaderet D, Faitel K, Jarandilla R, Garfinkel C, Klein S, Rubenfire M.
    Am J Cardiol; 1986 Jan 01; 57(1):128-30. PubMed ID: 3942055
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.